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http://www.biomedcentral.com/1471-2466/14/16RESEARCH ARTICLE Open AccessIncreased difference between slow and forced
vital capacity is associated with reduced exercise
tolerance in COPD patients
Wei Yuan1, Xin He1, Qiu-Fen Xu1, Hao-Yan Wang1* and Richard Casaburi2Abstract
Background: A higher slow vital capacity (VC) compared with forced vital capacity (FVC) indicates small airway collapse
and air trapping. We hypothesized that a larger difference between VC and FVC (VC-FVC) would predict impaired
exercise capacity in patients with chronic obstructive pulmonary disease (COPD).
Methods: Pulmonary function and incremental cardiopulmonary exercise responses were assessed in 97 COPD patients.
Patients were then divided into two groups: one in which VC > FVC (n = 77) and the other in which VC≤ FVC (n = 20).
Results: Patients with VC > FVC had lower FEV1 and peak oxygen uptake (VO2/kg) compared with patients with VC≤
FVC. There was a significant inverse correlation for the entire group between VC-FVC and peak VO2/kg (r = -0.404;
p < 0.001). There was also a direct correlation between FEV1% pred and peak VO2/kg (r = 0.418; p < 0.001). The results of
the multivariate regression analysis with peak VO2/kg as the dependent variable showed that VC-FVC, FEV1(% pred) and
age were all significant independent predictors of peak VO2/kg. The model explained 35.9% of the peak VO2/kg variance.
Conclusions: The difference between VC and FVC, easily measured by spirometry, can be used not only as an index of
severity of airflow limitation, but also to predict exercise performance in COPD patients.
Keywords: Chronic obstructive pulmonary disease, Spirometry, ExerciseBackgrounds
Persistent and progressive airflow limitation is a main
characteristic of chronic obstructive pulmonary disease
(COPD) [1]. As a result, patients with COPD experience
dyspnea and impaired exercise capacity that progress
over time. The disease severity has usually been graded
based on the degree of airflow limitation, as measured
by a reduced forced expiratory volume in one second
(FEV1). However, there is only a weak correlation be-
tween FEV1, symptoms and impairment of a patient’s
health-related quality of life [1]. The long-term rate of
deterioration in exercise capacity in patients with COPD
was found to be more rapid than the rate of decline in
FEV1. The change in peak oxygen uptake (VO2) over time
was only weakly correlated with the change in FEV1 [2].
On the other hand, measurements of lung volumes, such* Correspondence: haoyanw@126.com
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unless otherwise stated.as the inspiratory capacity (IC), correlate better with pa-
tient functional capabilities than do measurements of
FEV1 [3-5].
IC has been wildly used to study pulmonary hyperin-
flation because it can be simply measured by spirometry.
A low resting IC reflects pulmonary hyperinflation, which
is defined as an abnormally increased lung volume at the
end of tidal expiration and is present in moderate to se-
vere COPD due to expiratory flow limitation and destruc-
tive changes of emphysema. Serial IC measurements have
be used to track dynamic hyperinflation (DH) during exer-
cise, which occurs when ventilatory demand increases,
leaving less time for expiration and resulting in air trap-
ping within the lungs [6-8]. Several studies have showed
that reduction in resting IC or dynamic IC constrains tidal
volume expansion during exercise and contributes import-
antly to reduced exercise performance in patients with
COPD [6,7,9,10].
Vital capacity, simply measured by spirometry, is a lung
volume measurement that can be measured as slow vitald. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Patient characteristics
Characteristics Data
Male 97
Age, yr 64±8
Weight, kg 70.37±10.68
VC, L 2.72±0.72
FVC, L 2.56±0.74
VC-FVC, † L 0.11 (0.02-0.24)
FEV1, L 1.31±0.54
FEV1, % predicted 48.85±18.13
FEV1/FVC, % 50.44±10.69
Peak VO2, ml/min/kg 14.45±4.92
Peak work rate, watts 71.98±34.98
Peak HR, beats/min 128±16
Data with normal distribution are presented as mean ± SD.
†: Expressed as median (interquartile range).
VC = vital capacity; FVC = forced vital capacity; FEV1 = forced expiratory volume
in one second; VC-FVC = difference between VC and FVC; VO2 = oxygen uptake;
HR = heart rate.
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or no difference between VC and FVC (VC-FVC) in nor-
mal subjects [11]. However, some studies have found that
FVC is smaller than VC both in asthma patients and
COPD patients and the difference between the two param-
eters is related to airflow limitation, small airway collapse
and gas trapping [11-13].
We hypothesized that COPD patients with larger dif-
ference between VC and FVC would have lower exercise
capacity. To test this hypothesis, we performed spirom-
etry and cardiopulmonary exercise testing and examined
the relationship of the difference between VC and FVC
to exercise performance in patients with COPD.
Methods
Subjects
We recruited 97 patients with COPD who satisfied the
following criteria: FEV1/FVC ratio < 0.7 and FEV1 of 30 to
80% predicted after inhalation of 400 ug albuterol [1] and
in a stable condition for at least 6 weeks. Patients with diag-
noses of interstitial lung disease or asthma were excluded.
All patients received written and verbal information about
the exercise testing. The study was approved by the Ethics
Committee of Beijing Friendship Hospital.
Pulmonary function tests
Spirometry, including VC, FVC and FEV1 was performed
using MasterScreen system (MasterScreen Body, CareFu-
sion, Hoechberg, Germany) before exercise testing in all
subjects. Procedures were carried out according to ATS/ERS
standards [14]. VC was obtained by asking subjects to take
in a full inspiration and then breathe out to the limit of full
expiration in a relaxed manner except near end-inspiration
and end-expiration. VC maneuvers was performed before
FVC maneuvers, each of which was performed 3 times, with
the highest value of each selected.
Exercise testing
Patients performed a progressive incremental exercise test-
ing to a symptom-limited maximum on an electronically
braked cycle ergometer (ViaSprint, CareFusion, Hoechberg,
Germany). The protocol consisted of 3 minutes of rest,
3 minutes of unloaded pedaling, and minute-by-minute
increments at a work rate of 5 to 20 W/min. Minute
ventilation, oxygen uptake (VO2), and carbon dioxide out-
put (VCO2) were acquired breath-by-breath using a com-
puterized system (OxyconDelta, CareFusion, Hoechberg,
Germany). Maximal heart rate (HR) predicted for age was
calculated as 220-age [15].
Statistical analysis
Data with normal distribution are presented as means ± SD
and data not normally distributed are presented as median
and interquartile range. Patients were classified into twogroups using the difference between VC and FVC: one
group with VC > FVC and the other group with VC ≤ FVC.
Differences between the two groups were analyzed using
independent sample t-tests. Comparison between the
two groups in VC-FVC was performed using the Mann-
Whitney U-test. Correlations between lung function and
exercise variables were assessed by Pearson’s correlation co-
efficient. A multivariate linear regression analysis was used
to determine the independent association of lung function
and other variables with exercise capacity. A p-value of less
than 0.05 was considered statistically significant.Results
Ninety seven patients with COPD were involved in this
study. Of these, 4 patients were staged as mildly impaired
(spirometry stage 1), 35 patients were moderately impaired
(stage 2), 49 patients were severely impaired (stage 3), and
9 patients were very severely impaired (stage 4) according
to GOLD classification [1]. The descriptive characteristics
of the subjects are summarized in Table 1.
The patients were divided into those with VC > FVC
(n = 77) and those with VC ≤ FVC (n = 20). The lung func-
tion and exercise parameters of these two groups are
shown in Table 2. The mean age was similar in the two
groups. Patients with VC > FVC had lower FEV1 and peak
VO2/kg compared with patients with VC ≤ FVC (Figure 1).
The peak work rate reached in the group of patients with
VC > FVC was lower than in the patients with VC ≤ FVC,
but without reaching statistical significance. There was no
significant difference in heart rate at peak exercise be-
tween the two groups.
Figure 2 Relationship between VC-FVC and peak VO2/kg. There
was a significant inverse correlation for the entire group between
VC-FVC and peak VO2/kg (r = -0.404; p < 0.001).
Table 2 Lung function and exercise responses of patients
with COPD classified by difference between VC and FVC
VC > FVC VC ≤ FVC p-value
Patients, n 77 20
Age, yr 65±8.2 62±7.7 0.187
VC-FVC, † L 0.16 (0.07-0.27) -0.20 (-0.30–0.03) <0.001
FEV1, L 1.21±0.46 1.67±0.68 0.008
FEV1, % predicted 46.41±16.13 58.26±22.44 0.009
FEV1/FVC, % 49.29±10.49 54.89±10.54 0.036
Peak VO2, ml/min/kg 13.26±3.92 18.99±5.75 <0.001
Peak work rate, watts 68.53±34.45 85.10±34.74 0.059
Peak HR, beats/min 128±16 128±11 0.983
Data with normal distribution are presented as mean ± SD.
†: Expressed as median (interquartile range).
VC = vital capacity; FVC = forced vital capacity; FEV1 = forced expiratory volume
in one second; VC-FVC = difference between VC and FVC; VO2 = oxygen uptake;
HR = heart rate.
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group between VC-FVC and peak VO2/kg (r = -0.404; p <
0.001) (Figure 2). There was also a direct correlation be-
tween FEV1 % pred and peak VO2/kg (r = 0.418; p < 0.001)
(Figure 3).
The results of the multivariate regression analysis with
peak VO2/kg as the dependent variable is presented in
Table 3. Difference between VC and FVC, FEV1% pred
and age were all significant and independent predictors
of peak VO2/kg. The model explains 35.9% of the peak
VO2 variance.Discussion
In this study, patients with VC > FVC had a lower FEV1
and a lower peak VO2/kg, compared with those withFigure 1 Peak VO2/kg in COPD patients with VC > FVC and
VC ≤ FVC. Patients with VC > FVC had a lower peak VO2/kg
compared with patients with VC≤ FVC (p < 0.001).VC ≤ FVC. There was a significant and inverse correlation
for the entire group between VC-FVC and peak VO2/kg.
There was also a direct correlation between FEV1 % pred
and peak VO2/kg. The results of the multivariate regres-
sion analysis show that difference between VC and FVC,
FEV1 % pred and age were significantly independent pre-
dictors of peak VO2/kg. These results support our hy-
pothesis that a larger difference between VC and FVC is
associated with reduced exercise capacity in patients
with COPD.
FVC is defined as the volume of air exhaled with max-
imal forced effort from a maximal inspiration. VC is
similar to the FVC, but the maneuver is not forced and
it is performed in a relaxed manner, except near the
end-inspiration and end-expiration. Several studies have
explored differences between VC and FVC and theirFigure 3 Relationship between FEV1, % predicted and peak
VO2/kg. There was a direct correlation between FEV1 % pred and
peak VO2/kg (r = 0.418; p < 0.001).
Table 3 Multivariate regression analysis in COPD patients
with VO2 (in ml/min/kg) at peak exercise as the
dependent variable
Independent variable Coefficient p-value
Age, yr -0.173 0.001
FEV1, % predicted 0.098 <0.001
VC-FVC, L -5.122 0.001
VC-FVC = difference between VC and FVC; FEV1 = forced expiratory volume in
one second.
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evaluated the FVC/VC ratio in patients with bronchiolitis
obliterans syndrome occurring after lung transplantation,
in which small airways become progressively obliterated,
leading to airway obstruction. They found that FVC/VC
ratio decreased significantly with progressing bronchiolitis
obliterans stages, which occurred independently of changes
in FEV1. In asthma patients, it has been described that the
difference between VC and FVC increases as the degree
of obstruction increases. The difference can be used as
an indicator of air trapping [11,17]. Similar results were
found in the present study. We showed that FEV1% pre-
dicted was lower in patients with VC > FVC than in
those with VC ≤ FVC, suggesting that difference be-
tween VC and FVC was significantly associated with the
degree of airflow obstruction. There were 20 patients with
VC ≤ FVC. The underlying mechanism for larger FVC
than VC remains uncertain.
Although VC and FVC are often measured in lung func-
tion laboratory, the difference between them has less been
evaluated. To our knowledge, there have been no previous
studies describing the relationship between the difference
(VC-FVC) and exercise capacity in patients with COPD.
The current study explored this relationship and showed
that there was a significant and inverse correlation be-
tween VC-FVC and peak VO2/kg (r = -0.404; p < 0.001).
Combined with FEV1% predicted and age, the difference
between VC and FVC could significantly account for
35.9% of the peak VO2/kg variance. This finding has an
important implication for clinical practice. The difference
between VC and FVC, simply measured by spirometry,
can be used to predict exercise capacity in patients with
COPD.
We may speculate on the underlying mechanism of as-
sociation between the difference (VC-FVC) and exercise
capacity. The first issue to consider is why a difference
between VC and FVC exists in COPD. This has been ex-
plained by the following mechanism. Small airways, de-
fined as those smaller than 2 mm in diameter, have no
cartilaginous support and are subject to collapse when
compressed [18]. During a slow VC maneuver, less thor-
acic gas compression occurs and greater air volume can
be expired. In contrast, during an FVC maneuver, greaterairway compression occurs and a smaller volume is ex-
pired. However, in healthy people this tendency is partly
opposed by the attachment of the alveolar septa to the air-
way walls. In those with COPD, the airways tend to col-
lapse during a forced expiration due to the reduction of
alveolar attachments and airway abnormalities. Therefore,
finding that VC is higher than FVC suggests small airway
collapse and air trapping [17]. It further may indicate that
static pulmonary hyperinflation is present. Since pulmon-
ary hyperinflation constrains tidal volume expansion dur-
ing exercise and contributes importantly to reduced
exercise performance in patients with COPD, this seems a
likely explanation for the association of the difference be-
tween VC and FVC and reduced exercise capacity in pa-
tients with COPD.
A limitation of the present study is that we did not
measure inspiratory capacity during exercise, so as to
better quantitate dynamic hyperinflation and more pre-
cisely reveal the mechanisms of association between VC-
FVC and exercise performance in patients with COPD.
This should be addressed in future studies.Conclusion
We have studied the association between VC, FVC and
exercise capacity in patients with COPD. We found
that the difference between VC and FVC at rest, which
is easily obtained from spirometric results and does not
depend on predicted population values, can be used
not only as an index of severity of airflow limitation,
but also to predict exercise performance in patients
with COPD.
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